Literature DB >> 3286508

Persistence of Yersinia enterocolitica in man.

J A Hoogkamp-Korstanje1, J de Koning, J Heesemann.   

Abstract

Ten patients with chronic Yersinia enterocolitica infections are described. The initial diagnosis was made by culture, significant agglutinin titres and indirect immunofluorescence (IF) on biopsies. During the chronic phase, culture and agglutinin titres were negative, but specific serum IgA and IgG antibodies reactive with at least two, i.e. the 36 kDa and the 46 kDa, virulence-associated released proteins were demonstrated in nine patients by immunoblot techniques. One patient had only IgG antibodies. The chronically elevated IgA production was the result of chronic stimulation of the gut-associated lymphoid tissue by virulent persistent Yersinia antigen, which was identified by IF with O-specific antiserum and monospecific antiserum to the 46 kDa released protein in biopsies. Virulent Yersinia bacilli were demonstrated in the intestinal mucosa and in the lymphoid tissue of the submucosa associated with macrophages in patients with chronic ileitis and arthritis, in granulomatous centres of lymph nodes in patients with chronic lymphadenopathy and in portal infiltrates in a patient with chronic hepatitis. Recognition of persistent Yersinia infections may have therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3286508     DOI: 10.1007/bf01644307

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  12 in total

1.  Antibiotics in Yersinia enterocolitica infections.

Authors:  J A Hoogkamp-Korstanje
Journal:  J Antimicrob Chemother       Date:  1987-07       Impact factor: 5.790

2.  Incidence of human infection with Yersinia enterocolitica serotypes O3, O8, and O9 and the use of indirect immunofluorescence in diagnosis.

Authors:  J A Hoogkamp-Korstanje; J de Koning; J P Samsom
Journal:  J Infect Dis       Date:  1986-01       Impact factor: 5.226

3.  Yersinia enterocolitica infection presenting as chronic enteropathic arthritis.

Authors:  M J Luzar; J H Caldwell; H Mekhjian; F B Thomas
Journal:  Arthritis Rheum       Date:  1983-09

4.  Follow-up studies of joint complications in yersiniosis.

Authors:  J L Kalliomäki; R Leino
Journal:  Acta Med Scand       Date:  1979

5.  IgA-anti-yersinia antibodies in yersinia triggered reactive arthritis.

Authors:  K Granfors; A Toivanen
Journal:  Ann Rheum Dis       Date:  1986-07       Impact factor: 19.103

6.  Persistence of IgM, IgG, and IgA antibodies to Yersinia in yersinia arthritis.

Authors:  K Granfors; M Viljanen; A Tiilikainen; A Toivanen
Journal:  J Infect Dis       Date:  1980-04       Impact factor: 5.226

7.  Genetically manipulated virulence of Yersinia enterocolitica.

Authors:  J Heesemann; B Algermissen; R Laufs
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

8.  Efficacy of cold enrichment techniques for recovery of Yersinia enterocolitica from human stools.

Authors:  C H Pai; S Sorger; L Lafleur; L Lackman; M I Marks
Journal:  J Clin Microbiol       Date:  1979-06       Impact factor: 5.948

9.  Yersinia arthritis: demonstration of occult enteritis by 111indium leucocyte scanning.

Authors:  R M Bernstein; C G Mackworth-Young; S H Saverymutu; S Gupta; J P England; G R Hughes
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

10.  Immunochemical analysis of plasmid-encoded proteins released by enteropathogenic Yersinia sp. grown in calcium-deficient media.

Authors:  J Heesemann; U Gross; N Schmidt; R Laufs
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

View more
  40 in total

Review 1.  Bacteria-Triggered reactive arthritis: implications for antibacterial treatment.

Authors:  A Toivanen
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Antibody response against 26 and 46 kilodalton released proteins of yersinia in yersinia triggered reactive arthritis.

Authors:  O Mäki-Ikola; M Pulz; J Heesemann; R Lahesmaa; R Saario; A Toivanen; K Granfors
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

Review 3.  HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations.

Authors:  Inés Colmegna; Raquel Cuchacovich; Luis R Espinoza
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

4.  Polyarteritis associated with Yersinia enterocolitica infection.

Authors:  K Pile; T Kwong; J Fryer; R Laurent
Journal:  Ann Rheum Dis       Date:  1992-05       Impact factor: 19.103

5.  Determination of oxygen radical production in spondyloarthropathies by whole blood chemiluminescence.

Authors:  M Ristola; M Leirisalo-Repo; H Repo
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

Review 6.  Potential role of superantigen induced activation of cell mediated immune mechanisms in the pathogenesis of Crohn's disease.

Authors:  J P Ibbotson; J R Lowes
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

7.  In situ localisation of Yersinia enterocolitica by catalysed reported deposition signal amplification.

Authors:  P T Odinot; J F Meis; J A Hoogkamp-Korstanje; W J Melchers
Journal:  J Clin Pathol       Date:  1998-06       Impact factor: 3.411

8.  Fatal Yersinia enterocolitica transfusion reaction.

Authors:  A Mewis; J Verhaegen; S Bourgeois; M Hiele; B Schelstraete
Journal:  J Clin Pathol       Date:  1997-09       Impact factor: 3.411

9.  Acute and chronic gastrointestinal manifestations associated with Yersinia enterocolitica infection. A Norwegian 10-year follow-up study on 458 hospitalized patients.

Authors:  A Saebø; J Lassen
Journal:  Ann Surg       Date:  1992-03       Impact factor: 12.969

10.  Development of rRNA-targeted PCR and in situ hybridization with fluorescently labelled oligonucleotides for detection of Yersinia species.

Authors:  K Trebesius; D Harmsen; A Rakin; J Schmelz; J Heesemann
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.